Inve India ▾

Lyka Labs share price & results

Lyka Labs· Healthcare

Results to
Jun 2026
Ownership as of
Sept 2026

Gujarat-based pharmaceutical manufacturer selling branded human and veterinary formulations in India and select export markets.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue42.3 ₹ crore+45.0% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin10.8 %−0.7 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit2.1 ₹ crore+159.3% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity-9.48 %−19.3 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-4.79 %+2.7 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)-2.61 %−31.6 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Price

₹79 −1.24% · −₹0.99

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −16.9% 1Y

₹60.0₹80.0Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26

1Y: ₹95.02 on 24 Oct 2025 → ₹79. High ₹95.12 (29 Oct 2025), low ₹44.95 (30 Mar 2026).

Previous close
₹79.99
Market cap
₹290 Cr
52-week range
₹44.95 – ₹95.12
One year
−16.13%
Return on equity (TTM to Jun 2026)
-9.48%

Overview

Symbol
NSE:LYKALABS
Exchange
NSE
Currency
INR

What Lyka Labs does

Based on the company's own presentations, annual report and earnings calls.

Lyka Labs Limited manufactures and markets pharmaceutical formulations for both human and veterinary use, sold under company brands domestically and exported to select international markets, including government-tender business. Manufacturing is carried out at the company's plant in Ankleshwar, Gujarat, supported by a dedicated Research & Development Centre in Andheri, Mumbai. The group includes related pharmaceutical entities Lyka Exports Limited, Lyka BDR International Limited and Lyka Generics Limited, alongside an associate relationship with Ipca Laboratories Limited.

Segments

  • Human pharmaceuticals
  • Veterinary pharmaceuticals
  • Export business
Manufacturing plants
1 (Ankleshwar, Gujarat)
R&D centres
1 (Andheri, Mumbai)
Business lines
Human + Veterinary formulations
Related pharma group entities
3 (Lyka Exports, Lyka BDR International, Lyka Generics)
Export presence
International markets incl. government tenders
Founded 1976Headquarters Mumbai, Maharashtra Company website

Your own record

Start an Inve Case for Lyka Labs

Free account: one company. Everything above stays public.

Write why you follow Lyka Labs and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse Lyka Labs

Guides on how to read this kind of business and the numbers that matter.